In-Licensing Services
Acquire the Right Assets for Your Pipeline
Partner with Vision Lifesciences to identify, evaluate, and secure innovative therapeutics and technologies from global sources.
Global Access
Source assets from innovators across Asia, Europe, and USA.
Due Diligence
Comprehensive scientific, commercial, and legal evaluation.
Competitive Terms
Negotiate optimal deal structures for your organization.
Risk Mitigation
Identify and address potential challenges early.
Proven Track Record in In-Licensing
We have helped clients across the globe acquire innovative assets and expand their pipelines through strategic in-licensing partnerships.
How Our In-Licensing Process Works
From opportunity identification to deal execution, we guide you through every step of the in-licensing journey.
Opportunity Identification
We scan the global landscape to identify assets that match your strategic priorities and therapeutic focus.
Asset Evaluation
Comprehensive due diligence including scientific assessment, IP review, competitive analysis, and commercial potential.
Negotiation
Structure and negotiate terms including territory rights, milestones, royalties, and development obligations.
Deal Execution
Manage contract finalization, regulatory handover, and technology transfer for seamless integration.
Opportunity Identification
We scan the global landscape to identify assets that match your strategic priorities and therapeutic focus.
Asset Evaluation
Comprehensive due diligence including scientific assessment, IP review, competitive analysis, and commercial potential.
Negotiation
Structure and negotiate terms including territory rights, milestones, royalties, and development obligations.
Deal Execution
Manage contract finalization, regulatory handover, and technology transfer for seamless integration.
Who This Is For
Our in-licensing services are designed for organizations looking to expand their portfolios with innovative assets from global sources.
Pharmaceutical Companies
Large and mid-sized pharma seeking to expand pipelines with innovative assets from global sources.
Biotech Companies
Growing biotechs looking to diversify their portfolios or acquire complementary technologies.
Specialty Pharma
Specialty and regional players seeking differentiated products for specific markets or therapeutic areas.
Why Choose Vision Lifesciences for In-Licensing
Our unique combination of global reach, asset expertise, and hands-on approach sets us apart in the licensing advisory space.
Tap into a vast network of global innovators.
Our relationships span across leading biotechs, academic institutions, and emerging pharma companies in Asia, Europe, and the USA. We connect you with asset owners you might not discover through traditional channels, giving you first-mover advantage on promising opportunities.